{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T14:11:52Z","timestamp":1776867112885,"version":"3.51.2"},"reference-count":109,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Primary biliary cholangitis (PBC), an autoimmune-mediated cholestatic liver disease with a female predominance, remains enigmatic in its pathogenesis despite advances in understanding immune dysregulation, bile acid dyshomeostasis, inflammatory cascades, gut-liver axis crosstalk, and sex-biased mechanisms. Although ursodeoxycholic acid is widely recognized as the first-line therapy, its variable efficacy underscores the need for novel biomarkers and targeted therapies. Non-coding RNAs (ncRNAs), though not encoding proteins, have emerged as promising candidates due to their pivotal regulatory roles in autoimmune processes. This review systematically delineates the interplay between ncRNAs (miRNAs, lncRNAs, circRNAs) and key PBC mechanisms, evaluates their diagnostic and therapeutic potential, and proposes future research frameworks to bridge molecular insights with clinical translation.<\/jats:p>","DOI":"10.3389\/fmed.2025.1611640","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T06:15:59Z","timestamp":1754288159000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Research progress and perspectives of non-coding RNAs in primary biliary cholangitis: from mechanisms to therapeutics"],"prefix":"10.3389","volume":"12","author":[{"given":"Wangqi","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxia","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41575-019-0226-7","article-title":"Primary biliary cholangitis: pathogenesis and therapeutic opportunities.","volume":"17","author":"Gulamhusein","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"111754","DOI":"10.1016\/j.biopha.2021.111754","article-title":"The pathogenesis, models and therapeutic advances of primary biliary cholangitis.","volume":"140","author":"Li","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"B3","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.cld.2022.06.011","article-title":"Hepatocellular carcinoma in primary biliary cholangitis.","volume":"26","author":"Sy","year":"2022","journal-title":"Clin Liver Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e0179","DOI":"10.1097\/HC9.0000000000000179","article-title":"Primary biliary cholangitis: epidemiology, prognosis, and treatment.","volume":"7","author":"Trivella","year":"2023","journal-title":"Hepatol Commun"},{"key":"B5","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.cld.2022.06.001","article-title":"Contemporary epidemiology of primary biliary cholangitis.","volume":"26","author":"Colapietro","year":"2022","journal-title":"Clin Liver Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3350\/cmh.2020.0028","article-title":"Current understanding of primary biliary cholangitis.","volume":"27","author":"Tanaka","year":"2021","journal-title":"Clin Mol Hepatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jhep.2020.09.011","article-title":"A placebo-controlled randomised trial of budesonide for PBC following an insufficient response to UDCA.","volume":"74","author":"Hirschfield","year":"2021","journal-title":"J Hepatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1111\/liv.14165","article-title":"Additional fibrate treatment in UDCA-refractory PBC patients.","volume":"39","author":"Chung","year":"2019","journal-title":"Liver Int."},{"key":"B9","doi-asserted-by":"publisher","first-page":"232","DOI":"10.14309\/ajg.0000000000002070","article-title":"Application of the latest advances in evidence-based medicine in primary biliary cholangitis.","volume":"118","author":"Kowdley","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1055\/s-0039-1697617","article-title":"The pathogenesis of primary biliary cholangitis: a comprehensive review.","volume":"40","author":"Lleo","year":"2020","journal-title":"Semin Liver Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1053\/j.gastro.2024.01.049","article-title":"Immunopathogenesis of primary biliary cholangitis, primary sclerosing cholangitis and autoimmune hepatitis: themes and concepts.","volume":"166","author":"Trivedi","year":"2024","journal-title":"Gastroenterology."},{"key":"B12","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41586-020-2396-4","article-title":"A metabolic pathway for bile acid dehydroxylation by the gut microbiome.","volume":"582","author":"Funabashi","year":"2020","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","first-page":"117853","DOI":"10.1016\/j.biopha.2025.117853","article-title":"Exosomes and non-coding RNAs: exploring their roles in human myocardial dysfunction.","volume":"183","author":"Kulus","year":"2025","journal-title":"Biomed Pharmacother."},{"key":"B14","doi-asserted-by":"publisher","first-page":"108466","DOI":"10.1016\/j.pharmthera.2023.108466","article-title":"Noncoding RNA circuitry in melanoma onset, plasticity, and therapeutic response.","volume":"248","author":"Grafanaki","year":"2023","journal-title":"Pharmacol Ther"},{"key":"B15","doi-asserted-by":"publisher","first-page":"188491","DOI":"10.1016\/j.bbcan.2020.188491","article-title":"Non-coding RNAs and potential therapeutic targeting in cancer.","volume":"1875","author":"Toden","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e202009045","DOI":"10.1083\/jcb.202009045","article-title":"LNCcation: lncRNA localization and function.","volume":"220","author":"Bridges","year":"2021","journal-title":"J Cell Biol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.tig.2022.02.006","article-title":"Emerging concepts of miRNA therapeutics: from cells to clinic.","volume":"38","author":"Diener","year":"2022","journal-title":"Trends Genet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1080\/15476286.2020.1853977","article-title":"New progresses of circular RNA biology: from nuclear export to degradation.","volume":"18","author":"Zhou","year":"2021","journal-title":"RNA Biol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41418-022-00948-7","article-title":"Specific expression and functions of circular RNAs.","volume":"29","author":"Misir","year":"2022","journal-title":"Cell Death Differ"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.3390\/biom10071044","article-title":"Long noncoding RNAs and circular RNAs in autoimmune diseases.","volume":"10","author":"Lodde","year":"2020","journal-title":"Biomolecules"},{"key":"B21","doi-asserted-by":"publisher","first-page":"114049","DOI":"10.1016\/j.intimp.2025.114049","article-title":"The roles and therapeutic potential of exosomal non-coding RNAs in microglia-mediated intercellular communication.","volume":"148","author":"Yang","year":"2025","journal-title":"Int Immunopharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41392-021-00779-x","article-title":"Roles and mechanisms of exosomal non-coding RNAs in human health and diseases.","volume":"6","author":"Li","year":"2021","journal-title":"Sig Transduct Target Ther"},{"key":"B23","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1042\/CS20181123","article-title":"Immunological abnormalities in patients with primary biliary cholangitis.","volume":"133","author":"Ma","year":"2019","journal-title":"Clin Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/hepr.13318","article-title":"CD4 + T cells from patients with primary biliary cholangitis show T cell activation and differentially expressed T-cell receptor repertoires.","volume":"49","author":"Nakagawa","year":"2019","journal-title":"Hepatol Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.21037\/atm-20-2427","article-title":"An enhanced level of LAMP-2A participates in CD4+T cell hyperactivity in patients with primary biliary cholangitis.","volume":"9","author":"Sun","year":"2021","journal-title":"Ann Transl Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.jhep.2022.06.014","article-title":"NUDT1 promotes the accumulation and longevity of CD103+ TRM cells in primary biliary cholangitis.","volume":"77","author":"Huang","year":"2022","journal-title":"J Hepatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00281-022-00940-w","article-title":"Challenges and opportunities in achieving effective regulatory T cell therapy in autoimmune liver disease.","volume":"44","author":"Richardson","year":"2022","journal-title":"Semin Immunopathol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"107820","DOI":"10.1016\/j.intimp.2021.107820","article-title":"5-Aza-2-deoxycytidine alleviates the progression of primary biliary cholangitis by suppressing the FoxP3 methylation and promoting the Treg\/Th17 balance.","volume":"96","author":"Jiang","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1055\/s-0039-1688751","article-title":"The contribution of B cells in autoimmune liver diseases.","volume":"39","author":"Taylor","year":"2019","journal-title":"Semin Liver Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41423-020-00568-6","article-title":"Antigen presentation, autoantibody production, and therapeutic targets in autoimmune liver disease.","volume":"18","author":"Horst","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.jhep.2023.08.016","article-title":"A+T rich interaction domain protein 3a (Arid3a) impairs Mertk-mediated efferocytosis in cholestasis.","volume":"79","author":"Chen","year":"2023","journal-title":"J Hepatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"616853","DOI":"10.3389\/fimmu.2021.616853","article-title":"Natural killer cells: potential biomarkers and therapeutic target in autoimmune diseases?","volume":"12","author":"Gianchecchi","year":"2021","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1256995","DOI":"10.3389\/fimmu.2023.1256995","article-title":"Regulation of CD47 expression on CD14+ monocytes by interferon-\u03b1 in PBC patients.","volume":"14","author":"Su","year":"2023","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"5872","DOI":"10.3390\/ijms23115872","article-title":"Interplay between mast cells and regulatory T cells in immune-mediated cholangiopathies.","volume":"23","author":"Krajewska","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"102534","DOI":"10.1016\/j.autrev.2020.102534","article-title":"The role of complement activation in autoimmune liver disease.","volume":"19","author":"Biewenga","year":"2020","journal-title":"Autoimmun Rev"},{"key":"B36","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.intimp.2018.09.027","article-title":"miR-181a regulates Th17 cells distribution via up-regulated BCL-2 in primary biliary cholangitis.","volume":"64","author":"Song","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.jhep.2017.02.002","article-title":"miR-425 regulates inflammatory cytokine production in CD4(+) T cells via N-Ras upregulation in primary biliary cholangitis.","volume":"66","author":"Nakagawa","year":"2017","journal-title":"J Hepatol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/hep.31724","article-title":"Enoxacin up-regulates MicroRNA biogenesis and down-regulates cytotoxic CD8 T-cell function in autoimmune cholangitis.","volume":"74","author":"Itoh","year":"2021","journal-title":"Hepatology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3390\/cells9010190","article-title":"Cholangiocyte-derived exosomal lncRNA H19 promotes macrophage activation and hepatic inflammation under cholestatic conditions.","volume":"9","author":"Li","year":"2020","journal-title":"Cells"},{"key":"B40","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.it.2022.04.002","article-title":"LNCing RNA to immunity.","volume":"43","author":"Peltier","year":"2022","journal-title":"Trends Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41576-023-00662-1","article-title":"Non-coding RNAs in disease: from mechanisms to therapeutics.","volume":"25","author":"Nemeth","year":"2024","journal-title":"Nat Rev Genet"},{"key":"B42","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41419-019-1744-5","article-title":"Roles of circular RNAs in immune regulation and autoimmune diseases.","volume":"10","author":"Zhou","year":"2019","journal-title":"Cell Death Dis"},{"key":"B43","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13578-023-01035-1","article-title":"Bile acid-mediated signaling in cholestatic liver diseases.","volume":"13","author":"Zeng","year":"2023","journal-title":"Cell Biosci"},{"key":"B44","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jhep.2022.07.034","article-title":"Secretin alleviates biliary and liver injury during late-stage primary biliary cholangitis via restoration of secretory processes.","volume":"78","author":"Kennedy","year":"2023","journal-title":"J Hepatol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/hep.32405","article-title":"Mechanisms and molecules: what are the treatment targets for primary biliary cholangitis?","volume":"76","author":"Mayo","year":"2022","journal-title":"Hepatology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/s41401-021-00849-4","article-title":"FXR: structures, biology, and drug development for NASH and fibrosis diseases.","volume":"43","author":"Tian","year":"2022","journal-title":"Acta Pharmacol Sin"},{"key":"B47","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/hep.25691","article-title":"Up-regulation of microRNA 506 leads to decreased Cl-\/HCO3- anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis.","volume":"56","author":"Banales","year":"2012","journal-title":"Hepatology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1074\/jbc.M114.587030","article-title":"Post-translational regulation of the type III inositol 1,4,5-trisphosphate receptor by miRNA-506.","volume":"290","author":"Ananthanarayanan","year":"2015","journal-title":"J Biol Chem"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1002\/hep.30966","article-title":"MicroRNA-210 promotes bile acid-induced cholestatic liver injury by targeting mixed-lineage leukemia-4 methyltransferase in mice.","volume":"71","author":"Kim","year":"2020","journal-title":"Hepatology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/hep.29209","article-title":"H19 promotes cholestatic liver fibrosis by preventing ZEB1-mediated inhibition of epithelial cell adhesion molecule.","volume":"66","author":"Song","year":"2017","journal-title":"Hepatology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41419-019-1423-6","article-title":"H19 potentiates let-7 family expression through reducing PTBP1 binding to their precursors in cholestasis.","volume":"10","author":"Zhang","year":"2019","journal-title":"Cell Death Dis"},{"key":"B52","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1097\/HEP.0000000000000611","article-title":"Bile acid\u2013induced IRF3 phosphorylation mediates cell death, inflammatory responses, and fibrosis in cholestasis-induced liver and kidney injury via regulation of ZBP1.","volume":"79","author":"Zhuang","year":"2024","journal-title":"Hepatology"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1150879","DOI":"10.3389\/fimmu.2023.1150879","article-title":"Inflammasome and pyroptosis in autoimmune liver diseases.","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.3724\/abbs.2022137","article-title":"NLRP3 inflammasome activation mechanism and its role in autoimmune liver disease.","volume":"54","author":"Guan","year":"2022","journal-title":"Acta Biochim Biophys Sin"},{"key":"B55","doi-asserted-by":"publisher","first-page":"5097","DOI":"10.3390\/ijms21145097","article-title":"Galectin-3 in inflammasome activation and primary biliary cholangitis development.","volume":"21","author":"Arsenijevic","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B56","doi-asserted-by":"publisher","first-page":"102940","DOI":"10.1016\/j.jaut.2022.102940","article-title":"Caspase-10 affects the pathogenesis of primary biliary cholangitis by regulating inflammatory cell death.","volume":"133","author":"Cho","year":"2022","journal-title":"J Autoimmun"},{"key":"B57","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.cmet.2020.11.018","article-title":"Apaf-1 pyroptosome senses mitochondrial permeability transition.","volume":"33","author":"Xu","year":"2021","journal-title":"Cell Metab"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1002\/hep.29533","article-title":"MicroRNA-506 promotes primary biliary cholangitis-like features in cholangiocytes and immune activation.","volume":"67","author":"Erice","year":"2018","journal-title":"Hepatology"},{"key":"B59","doi-asserted-by":"publisher","first-page":"110795","DOI":"10.1016\/j.ygeno.2024.110795","article-title":"HSCs-derived exosomes regulate the levels of inflammatory cytokines in HIBECs through miR-122-5p mediated p38 MAPK signaling pathway.","volume":"116","author":"Zhang","year":"2024","journal-title":"Genomics"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1159\/000485487","article-title":"Microarray expression profile of circular RNAs in plasma from primary biliary cholangitis patients.","volume":"44","author":"Zheng","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.ajpath.2023.06.010","article-title":"Sex-dependent differences in cholestasis: why estrogen signaling may be a key pathophysiological driver.","volume":"193","author":"Ismail","year":"2023","journal-title":"Am J Pathol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.cld.2022.06.008","article-title":"Primary biliary cholangitis in males.","volume":"26","author":"Shaker","year":"2022","journal-title":"Clin Liver Dis"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1002\/tox.23906","article-title":"Estrogen receptor alpha-mediated mitochondrial damage in intrahepatic bile duct epithelial cells leading to the pathogenesis of primary biliary cholangitis.","volume":"38","author":"Liang","year":"2023","journal-title":"Environ Toxicol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.bbadis.2017.09.022","article-title":"Role of the bicarbonate-responsive soluble adenylyl cyclase in cholangiocyte apoptosis in primary biliary cholangitis; a new hypothesis.","volume":"1864","author":"Chang","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"key":"B65","doi-asserted-by":"publisher","first-page":"98","DOI":"10.15430\/JCP.2021.26.2.98","article-title":"The role of sex-specific long non-coding RNAs in cancer prevention and therapy.","volume":"26","author":"Song","year":"2021","journal-title":"J Cancer Prev"},{"key":"B66","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/hep.29145","article-title":"The role of long noncoding RNA H19 in gender disparity of cholestatic liver injury in multidrug resistance 2 gene knockout mice.","volume":"66","author":"Li","year":"2017","journal-title":"Hepatology"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.gendis.2022.04.007","article-title":"Long noncoding RNA XIST: mechanisms for X chromosome inactivation, roles in sex-biased diseases, and therapeutic opportunities.","volume":"9","author":"Li","year":"2022","journal-title":"Genes Dis"},{"key":"B68","doi-asserted-by":"publisher","first-page":"816433","DOI":"10.3389\/fimmu.2022.816433","article-title":"Effect of LncRNA XIST on immune cells of primary biliary cholangitis.","volume":"13","author":"She","year":"2022","journal-title":"Front Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1097\/HEP.0000000000000506","article-title":"Role of microbiome in autoimmune liver diseases.","volume":"80","author":"Schneider","year":"2024","journal-title":"Hepatology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1273024","DOI":"10.3389\/fmicb.2023.1273024","article-title":"Causal associations between gut microbiota and primary biliary cholangitis: a bidirectional two-sample Mendelian randomization study.","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Microbiol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"e13714","DOI":"10.1111\/eci.13714","article-title":"Alterations in gut microbiota and elevated serum bilirubin in primary biliary cholangitis patients treated with ursodeoxycholic acid.","volume":"52","author":"Han","year":"2022","journal-title":"Eur J Clin Investig"},{"key":"B72","doi-asserted-by":"publisher","first-page":"fnab038","DOI":"10.1093\/femsle\/fnab038","article-title":"Short-chain fatty acid and fecal microbiota profiles are linked to fibrosis in primary biliary cholangitis.","volume":"368","author":"Lammert","year":"2021","journal-title":"FEMS Microbiol Lett"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1946366","DOI":"10.1080\/19490976.2021.1946366","article-title":"Alterations in microbiota and their metabolites are associated with beneficial effects of bile acid sequestrant on icteric primary biliary Cholangitis.","volume":"13","author":"Li","year":"2021","journal-title":"Gut Microbes"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1840766","article-title":"Host miRNA-21 promotes liver dysfunction by targeting small intestinal Lactobacillus in mice.","volume":"12","author":"Santos","year":"2020","journal-title":"Gut Microbes."},{"key":"B75","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.redox.2017.03.006","article-title":"Butyrate induces ROS-mediated apoptosis by modulating miR-22\/SIRT-1 pathway in hepatic cancer cells.","volume":"12","author":"Pant","year":"2017","journal-title":"Redox Biol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"102436","DOI":"10.1016\/j.jaut.2020.102436","article-title":"Multi-omics: Differential expression of IFN-\u03b3 results in distinctive mechanistic features linking chronic inflammation, gut dysbiosis, and autoimmune diseases.","volume":"111","author":"Bae","year":"2020","journal-title":"J Autoimmun."},{"key":"B77","doi-asserted-by":"publisher","first-page":"7167","DOI":"10.3390\/ijms23137167","article-title":"MicroRNA-based diagnosis and therapy.","volume":"23","author":"Ho","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B78","doi-asserted-by":"publisher","first-page":"895242","DOI":"10.3389\/fphys.2022.895242","article-title":"MicroRNA-34a: a novel therapeutic target in fibrosis.","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Physiol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"6890423","DOI":"10.1155\/2021\/6890423","article-title":"MicroRNA-34a promotes EMT and liver fibrosis in primary biliary cholangitis by regulating TGF-\u03b21\/smad pathway.","volume":"2021","author":"Pan","year":"2021","journal-title":"J Immunol Res"},{"key":"B80","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s10020-019-0130-1","article-title":"Enhanced expression of miR-21 and miR-150 is a feature of anti-mitochondrial antibody-negative primary biliary cholangitis.","volume":"26","author":"Wasik","year":"2020","journal-title":"Mol Med"},{"key":"B81","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.3892\/mmr.2016.5606","article-title":"Identification of microRNA profiles associated with refractory primary biliary cirrhosis.","volume":"14","author":"Sakamoto","year":"2016","journal-title":"Mol Med Rep"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1002\/hep4.1252","article-title":"H19 is expressed in hybrid hepatocyte nuclear factor 4\u03b1(+) periportal hepatocytes but not cytokeratin 19(+) cholangiocytes in cholestatic livers.","volume":"2","author":"Jiang","year":"2018","journal-title":"Hepatol Commun"},{"key":"B83","doi-asserted-by":"publisher","first-page":"154549","DOI":"10.1016\/j.prp.2023.154549","article-title":"A review on the role of LINC00472 in malignant and non-malignant disorders.","volume":"247","author":"Ghafouri-Fard","year":"2023","journal-title":"Pathol Res Pract"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.3748\/wjg.v27.i17.1973","article-title":"S100 calcium binding protein A6 and associated long noncoding ribonucleic acids as biomarkers in the diagnosis and staging of primary biliary cholangitis.","volume":"27","author":"Dong","year":"2021","journal-title":"World J Gastroenterol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/MOG.0000000000000708","article-title":"Primary biliary cholangitis: treatment.","volume":"37","author":"Cazzagon","year":"2021","journal-title":"Curr Opin Gastroenterol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"2208501","DOI":"10.1080\/19490976.2023.2208501","article-title":"Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis.","volume":"15","author":"Martinez-Gili","year":"2023","journal-title":"Gut Microbes"},{"key":"B87","doi-asserted-by":"publisher","first-page":"9667","DOI":"10.3390\/ijms21249667","article-title":"Melatonin protects cholangiocytes from oxidative stress-induced proapoptotic and proinflammatory stimuli via miR-132 and miR-34.","volume":"21","author":"Ostrycharz","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B88","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/s41418-017-0019-x","article-title":"miRNA-21 ablation protects against liver injury and necroptosis in cholestasis.","volume":"25","author":"Afonso","year":"2018","journal-title":"Cell Death Differ"},{"key":"B89","doi-asserted-by":"publisher","first-page":"212","DOI":"10.7150\/ijms.29930","article-title":"MicroRNA-29a is a key regulon that regulates BRD4 and mitigates liver fibrosis in mice by inhibiting hepatic stellate cell activation.","volume":"16","author":"Huang","year":"2019","journal-title":"Int J Med Sci."},{"key":"B90","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.3390\/cells11182880","article-title":"Suppression of hepatic PPAR\u03b1 in primary biliary cholangitis is modulated by miR-155.","volume":"11","author":"Adamowicz","year":"2022","journal-title":"Cells"},{"key":"B91","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jhep.2021.02.035","article-title":"Limb expression 1-like (LIX1L) protein promotes cholestatic liver injury by regulating bile acid metabolism.","volume":"75","author":"Li","year":"2021","journal-title":"J Hepatol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/s41419-021-03931-1","article-title":"Conditional depletion of macrophages ameliorates cholestatic liver injury and fibrosis via lncRNA-H19.","volume":"12","author":"Tian","year":"2021","journal-title":"Cell Death Dis"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.30662","article-title":"Cholangiocyte-derived exosomal long noncoding RNA H19 promotes hepatic stellate cell activation and cholestatic liver fibrosis.","volume":"70","author":"Liu","year":"2019","journal-title":"Hepatology"},{"key":"B94","doi-asserted-by":"publisher","first-page":"714","DOI":"10.3389\/fcell.2020.00714","article-title":"Circular RNA cMTO1 promotes PTEN expression through sponging miR-181b-5p in liver fibrosis.","volume":"8","author":"Jin","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/hep.29270","article-title":"Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression.","volume":"66","author":"Han","year":"2017","journal-title":"Hepatology"},{"key":"B96","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12920-020-00830-w","article-title":"Pinpointing miRNA and genes enrichment over trait-relevant tissue network in Genome-Wide Association Studies.","volume":"13","author":"Li","year":"2020","journal-title":"BMC Med Genomics"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1171512","DOI":"10.3389\/fphar.2023.1171512","article-title":"Uncovering key molecules and immune landscape in cholestatic liver injury: implications for pathogenesis and drug therapy.","volume":"14","author":"Song","year":"2023","journal-title":"Front Pharmacol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1124956","DOI":"10.3389\/fmolb.2023.1124956","article-title":"Identification of AKR1B10 as a key gene in primary biliary cholangitis by integrated bioinformatics analysis and experimental validation.","volume":"10","author":"Wang","year":"2023","journal-title":"Front Mol Biosci"},{"key":"B99","doi-asserted-by":"publisher","first-page":"18274","DOI":"10.1039\/d4nr02795g","article-title":"Unleashing nanotechnology to redefine tumor-associated macrophage dynamics and non-coding RNA crosstalk in breast cancer.","volume":"16","author":"Patni","year":"2024","journal-title":"Nanoscale"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.ymthe.2023.01.021","article-title":"Extracellular vesicles: the next generation in gene therapy delivery.","volume":"31","author":"Cecchin","year":"2023","journal-title":"Mol Ther"},{"key":"B101","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.apsb.2020.10.001","article-title":"Long non-coding RNAs: from disease code to drug role.","volume":"11","author":"Chen","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"B102","doi-asserted-by":"publisher","first-page":"102982","DOI":"10.1016\/j.jaut.2022.102982","article-title":"Non-coding RNAs in immunoregulation and autoimmunity: technological advances and critical limitations.","volume":"134","author":"Kumar","year":"2023","journal-title":"J Autoimmun"},{"key":"B103","doi-asserted-by":"publisher","first-page":"qzae023","DOI":"10.1093\/gpbjnl\/qzae023","article-title":"SCancerRNA: expression at the single-cell level and interaction resource of non-coding RNA biomarkers for cancers.","volume":"22","author":"Guo","year":"2024","journal-title":"Genomics Proteomics Bioinformat"},{"key":"B104","doi-asserted-by":"publisher","first-page":"108373","DOI":"10.1016\/j.celrep.2020.108373","article-title":"Rapid and scalable profiling of nascent RNA with fastGRO.","volume":"33","author":"Barbieri","year":"2020","journal-title":"Cell Rep"},{"key":"B105","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1093\/nar\/gku1198","article-title":"Targeting non-coding RNAs with the CRISPR\/Cas9 system in human cell lines.","volume":"43","author":"Ho","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"B106","doi-asserted-by":"publisher","first-page":"7637","DOI":"10.1016\/j.cell.2024.10.021","article-title":"Transcriptome-scale RNA-targeting CRISPR screens reveal essential lncRNAs in human cells.","volume":"187","author":"Liang","year":"2024","journal-title":"Cell."},{"key":"B107","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00438-020-01727-0","article-title":"Recent advances on the machine learning methods in predicting ncRNA-protein interactions.","volume":"296","author":"Zhong","year":"2021","journal-title":"Mol Genet Genomics"},{"key":"B108","doi-asserted-by":"publisher","first-page":"bbac495","DOI":"10.1093\/bib\/bbac495","article-title":"Predicting miRNA-disease associations based on lncRNA-miRNA interactions and graph convolution networks.","volume":"24","author":"Wang","year":"2023","journal-title":"Brief Bioinform"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3390\/pathogens11091005","article-title":"MicroRNA-122 Regulation of HCV Infections: insights from Studies of miR-122-independent replication.","volume":"11","author":"Panigrahi","year":"2022","journal-title":"Pathogens"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1611640\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T06:16:00Z","timestamp":1754288160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1611640\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":109,"alternative-id":["10.3389\/fmed.2025.1611640"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1611640","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,4]]},"article-number":"1611640"}}